Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Breast Cancer

  Free Subscription

Articles published in Am J Surg Pathol

Retrieve available abstracts of 15 articles:
HTML format

Single Articles

    April 2021
  1. KUSAFUKA K, Yamada H, Ishino K, Maeda M, et al
    Salivary Duct Carcinoma With Rhabdoid Features-No or Aberrant Expression of E-cadherin and Genetic Changes in CDH1: Immunohistochemical and Genetic Analyses of 17 Cases.
    Am J Surg Pathol. 2021;45:439-449.
    PubMed     Abstract available

  2. MACCOLL CE, Pare G, Salehi A, Hodgson N, et al
    Postneoadjuvant Pure and Predominantly Pure Intralymphatic Breast Carcinoma: Case Series and Literature Review.
    Am J Surg Pathol. 2021;45:537-542.
    PubMed     Abstract available

    January 2021
  3. DUSENBERY AC, Maniaci JL, Hillerson ND, Dill EA, et al
    MHC Class I Loss in Triple-negative Breast Cancer: A Potential Barrier to PD-1/PD-L1 Checkpoint Inhibitors.
    Am J Surg Pathol. 2021 Jan 11. doi: 10.1097/PAS.0000000000001653.
    PubMed     Abstract available

    September 2020
  4. NORKOWSKI E, Masliah-Planchon J, Le Guellec S, Trassard M, et al
    Lower Rate of CTNNB1 Mutations and Higher Rate of APC Mutations in Desmoid Fibromatosis of the Breast: A Series of 134 Tumors.
    Am J Surg Pathol. 2020;44:1266-1273.
    PubMed     Abstract available

    August 2020
  5. ZHONG E, Solomon JP, Cheng E, Baum J, et al
    Apocrine Variant of Pleomorphic Lobular Carcinoma In Situ: Further Clinical, Histopathologic, Immunohistochemical, and Molecular Characterization of an Emerging Entity.
    Am J Surg Pathol. 2020;44:1092-1103.
    PubMed     Abstract available

    February 2020
  6. GRABENSTETTER A, Brennan S, Salagean ED, Morrow M, et al
    Flat Epithelial Atypia in Breast Core Needle Biopsies With Radiologic-Pathologic Concordance: Is Excision Necessary?
    Am J Surg Pathol. 2020;44:182-190.
    PubMed     Abstract available

  7. SLODKOWSKA E, Xu B, Kos Z, Bane A, et al
    Predictors of Outcome in Mammary Adenoid Cystic Carcinoma: A Multi-Institutional Study.
    Am J Surg Pathol. 2020;44:214-223.
    PubMed     Abstract available

    January 2020
  8. SHABIHKHANI M, Simpson JF, White MJ, Cimino-Mathews A, et al
    Artifactual Displacement of Ductal Carcinoma In Situ (ADDCIS) (Toothpaste Effect): A Mimicker of Invasive Ductal Carcinoma.
    Am J Surg Pathol. 2020;44:120-128.
    PubMed     Abstract available

  9. ZHONG E, Cheng E, Goldfischer M, Hoda SA, et al
    Papillary Lesions of the Male Breast: A Study of 117 Cases and Brief Review of the Literature Demonstrate a Broad Clinicopathologic Spectrum.
    Am J Surg Pathol. 2020;44:68-76.
    PubMed     Abstract available

  10. CLINTON LK, Plesec T, Goldblum JR, Hajifathalian K, et al
    Specific Histopathologic Features Aid in Distinguishing Diffuse-type Gastric Adenocarcinoma From Metastatic Lobular Breast Carcinoma.
    Am J Surg Pathol. 2020;44:77-86.
    PubMed     Abstract available

    July 2019
  11. VAN ES SC, van der Vegt B, Bensch F, Gerritse S, et al
    Decalcification of Breast Cancer Bone Metastases With EDTA Does Not Affect ER, PR, and HER2 Results.
    Am J Surg Pathol. 2019 Jul 5. doi: 10.1097/PAS.0000000000001321.
    PubMed     Abstract available

    January 2019
  12. LAURENT E, Begueret H, Bonhomme B, Veillon R, et al
    SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung Adenocarcinoma.
    Am J Surg Pathol. 2019 Jan 8. doi: 10.1097/PAS.0000000000001216.
    PubMed     Abstract available

    October 2018
  13. STEINER DF, MacDonald R, Liu Y, Truszkowski P, et al
    Impact of Deep Learning Assistance on the Histopathologic Review of Lymph Nodes for Metastatic Breast Cancer.
    Am J Surg Pathol. 2018 Oct 12. doi: 10.1097/PAS.0000000000001151.
    PubMed     Abstract available

    November 2017
  14. PATEL A, D'Alfonso T, Cheng E, Hoda SA, et al
    Sentinel Lymph Nodes in Classic Invasive Lobular Carcinoma of the Breast: Cytokeratin Immunostain Ensures Detection, and Precise Determination of Extent, of Involvement.
    Am J Surg Pathol. 2017;41:1499-1505.
    PubMed     Abstract available

    September 2017
  15. CHENG E, Ko D, Nguyen M, Moo TA, et al
    Residual Pure Intralymphatic Breast Carcinoma Following Neoadjuvant Chemotherapy Is Indicative of Poor Clinical Outcome, Even in Node-Negative Patients.
    Am J Surg Pathol. 2017;41:1275-1282.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.